Medical Cannabis for Lupus and Autoimmune Conditions

Autoimmune Conditions and Cannabis

• Systemic lupus erythematosus affects approximately 50,000 people in the UK
• The endocannabinoid system regulates immune function, inflammation, and pain signalling
• CB2 receptors on immune cells may modulate autoimmune activity
• Medical cannabis is used for pain, fatigue, and sleep in autoimmune conditions

Autoimmune conditions including lupus and rheumatoid arthritis are among those assessed by UK medical cannabis specialists.

Evidence and Clinical Considerations

• CBD has anti-inflammatory and immunomodulatory properties demonstrated in preclinical models
• Observational data shows improvements in pain and quality of life in lupus patients using cannabis
• Always disclose all medications — interactions with immunosuppressants are possible
• Cannabis is adjunct to — not replacement for — disease-modifying treatment

The complexity of lupus management means medical cannabis is typically considered alongside established disease-modifying treatment, not as a replacement.